ADVANCE

ADVANCE-ON: Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

Top

Zoungas S, Chalmers J, Neal B, et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014;[epub ahead of print]. doi: 10.1056/NEJMoa1407963.

Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy.

Top

Exclusive! Expert commentary webcast from Vivian Fonseca, MD, on this post-hoc analysis of ADVANCE. Morton J, Zoungas S, Li Q, et al; on behalf of the ADVANCE Collaborative Group. Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy. Diabetes Care. 2012;35:2201-2206. Macro- and microvascular complications remain significant concerns in the treatment of patients with type 2 diabetes.

Blood pressure variables and cardiovascular risk: new findings from ADVANCE

Top

Kengne AP, Czernichow S, Huxley R, et al, for the ADVANCE Collaborative Group. Blood pressure variables and cardiovascular risk: new findings from ADVANCE. Hypertension. 2009;54(2):399-404. The relative importance of various blood pressure indices on cardiovascular risk in people with type 2 diabetes mellitus has not been established.

Anti-diabetic agents in type 2 diabetes: a review of new data presented and discussed on the EASD meeting in Rome

Top

de Valk HW. Anti-diabetic agents in type 2 diabetes: a review of new data presented and discussed on the EASD meeting in Rome. Rev Diabet Stud. 2008;5(3):184-188. The results of a number of large trials and the arrival of new glucose-lowering drugs are changing the scene of diabetes care in patients with type 2 diabetes.

Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study

Top

Jakicic JM, Jaramillo SA, Balasubramanyam A, et al. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Int J Obesity. 2009 Jan 20. [Epub ahead of print]. Objective: To examine the effect of an intensive lifestyle weight loss intervention (ILI) compared to diabetes support and education (DSE) on changes in fitness and physical activity in the Look AHEAD trial.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Top

ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-2572. In patients with type 2 diabetes, the effects of intensive glucose control on vascular outcomes remain uncertain.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.Intensive blood glucose control and vascular outcomes

Top

ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-2572. In patients with type 2 diabetes, the effects of intensive glucose control on vascular outcomes remain uncertain.